Verified Nov 2026
Other
·

Gentilly, Ile-de-France
·
Since 1953
Biocodex is an independent, family-owned pharmaceutical company founded in 1953 in Gentilly, France, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops microbiota-focused therapies, probiotics, and treatments across gastroenterology, women's health, and orphan diseases, operating in over 115 countries. In 2026, the company invested €15 million in a dedicated platform for live biotherapeutics manufacturing.
Biocodex at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1953
Headquarters
Gentilly, Ile-de-France
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Biocodex is an independent, family-owned pharmaceutical company founded in 1953 in Gentilly, France, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops microbiota-focused therapies, probiotics, and treatments across gastroenterology, women's health, and orphan diseases, operating in over 115 countries. In 2026, the company invested €15 million in a dedicated platform for live biotherapeutics manufacturing.
At a glance
Attribute | Detail |
|---|---|
Founded | 1953 |
Headquarters | Gentilly, Ile-de-France |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Biocodex makes
The company specializes in probiotics including its proprietary Saccharomyces boulardii CNCM I-745® yeast strain, alongside prescription medications, medical devices, food supplements, and dermocosmetics.
Products and capabilities described on the company's own site include LED (source: biocodex.com).
Latest developments
2026-11-09 — Biocodex (Oise) investit 15 millions d’euros dans les produits biothérapeutiques vivants - Courrier picard (courrier-picard.fr)
2026-11-05 — Biocodex strengthens its industrial capabilities in microbiome-based live biotherapeutics with a new dedicated platform (biocodex.com)
2026-11-05 — MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines | santé log (santelog.com)
2026-05-26 — In Beauvais, Elcimaï is modernizing Biocodex’s historic production facility - ELCIMAI (elcimai.com)
2026-04-23 — PrecisionBiotics® (Novonesis) and Biocodex Mark Next Phase of Strategic Partnership with New Agreement (prnewswire.com)
2026-02-11 — THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases - Biocodex.com (biocodex.com)
Facilities
Biocodex is headquartered in Gentilly, Ile-de-France. Public sources also reference these locations:
France — biocodex.com
Company details
Biocodex operates as a privately held multinational with an integrated R&D center in France and strategic partnerships including a 2026 agreement with PrecisionBiotics (Novonesis) on probiotic strain development. Biocodex was founded in 1953, has an estimated 1,000-5,000 employees, and is headquartered in Gentilly, Ile-de-France.
Frequently asked questions
What does Biocodex do?
Biocodex is an independent, family-owned pharmaceutical company founded in 1953 in Gentilly, France, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops microbiota-focused therapies, probiotics, and treatments across gastroenterology, women's health, and orphan diseases, operating in over 115 countries. In 2026, the company invested €15 million in a dedicated platform for live biotherapeutics manufacturing.
Where is Biocodex headquartered?
Biocodex is headquartered in Gentilly, Ile-de-France (7 Avenue Gallieni, Gentilly, Ile-de-France, 94250).
When was Biocodex founded?
Biocodex was founded in 1953.
How big is Biocodex?
Biocodex has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
